Non-immunogenic polypeptides
First Claim
1. A physiologically active, substantially non-immunogenic water soluble polypeptide composition comprising, a physiologically active polypeptide coupled with a coupling agent toat least one substantially linear polymer having a molecular weight of between about 500 to about 20,000 daltons selected from the group consisting of polyethylene glycol and polypropropylene glycolwherein the polymer is unsubstituted or substituted by alkoxy or alkyl groups, said alkoxy or alkyl group possessing less than 5 carbon atoms.
3 Assignments
0 Petitions
Accused Products
Abstract
Polypeptides such as enzymes and insulin are coupled to polyethylene glycol or polypropropylene glycol having a molecular weight of 500 to 20,000 daltons to provide a physiologically active non-immunogenic water soluble polypeptide composition. The polyethylene glycol or polypropylene glycol protect the polypeptide from loss of activity and the composition can be injected into the mammalian circulatory system with substantially no immunogenic response.
2661 Citations
27 Claims
-
1. A physiologically active, substantially non-immunogenic water soluble polypeptide composition comprising, a physiologically active polypeptide coupled with a coupling agent to
at least one substantially linear polymer having a molecular weight of between about 500 to about 20,000 daltons selected from the group consisting of polyethylene glycol and polypropropylene glycol wherein the polymer is unsubstituted or substituted by alkoxy or alkyl groups, said alkoxy or alkyl group possessing less than 5 carbon atoms.
-
14. A process of preparing a physiologically active, substantially non-immunogenic water soluble polypeptide composition from a polypeptide;
- originally having physiological activity and immunogenicity which comprises the steps of;
(a) reacting at least one terminal carbon atom bearing a hydroxy group, of a substantially straight chain polymer selected from the group consisting of polyethylene glycol and polypropylene glycol having a molecular weight of from about 500 to about 20,000 daltons said polymer being unsubstituted or substituted by alkoxy or alkyl groups, said alkoxy or alkyl groups having less than 5 carbon atoms with a coupling agent to provide an activated polymer containing a reactive terminal group, and; (b) reacting a physiologically active immunogenic poly peptide with from 10 to 100 moles of said activated polymer per mole of poly peptide by coupling said polypeptide to the reactive terminal group of the polymer to provide said water soluble polypeptide composition. - View Dependent Claims (15, 16)
- originally having physiological activity and immunogenicity which comprises the steps of;
-
17. A physiologically active substantially non-immunogenic water soluble enzyme composition comprising a physiologically active enzyme coupled with a coupling agent to
at least one substantially linear polymer selected from the group consisting of polyethylene glycol and polypropylene glycol having molecular weight of between 500 and 20,000 daltons wherein the polymer moiety is unsubstituted or substituted by alkoxy or alkyl groups, said alkoxy or alkyl group possessing less than 5 carbon atoms.
-
23. A process of preparing a physiologically active, substantially non-immunogenic water soluble enzyme composition from an enzyme originally having physiological activity and immunogenicity which comprises the steps of:
-
(a) reacting at least one terminal carbon atom bearing a hydroxy group, of a substantially straight chain polymer selected from the group consisting of polyethylene glycol and polypropylene glycol having a molecular weight of from about 500 to about 20,000 daltons said polymer being unsubstituted or substituted by alkoxy or alkyl groups, said alkoxy or alkyl groups having less than 5 carbon atoms with a coupling agent to provide an activated polymer containing a reactive terminal group, and (b) reacting a physiologically active immunogenic enzyme with from 10 to 100 moles of said activated polymer per mole of enzyme by coupling the enzyme to the reactive terminal group of said polymer to provide said water soluble enzyme composition. - View Dependent Claims (24, 25, 26, 27)
-
Specification